Hemostemix Inc.
HMTXF
$0.0661
-$0.0011-1.64%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -24.02% | 10.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.02% | 9.50% | |||
| Operating Income | 24.02% | -9.50% | |||
| Income Before Tax | 39.24% | -7.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 39.24% | -7.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 39.24% | -7.60% | |||
| EBIT | 24.02% | -9.50% | |||
| EBITDA | 24.02% | -9.50% | |||
| EPS Basic | 40.91% | -10.00% | |||
| Normalized Basic EPS | 37.04% | -8.00% | |||
| EPS Diluted | 40.91% | -10.00% | |||
| Normalized Diluted EPS | 37.04% | -8.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||